Who we are
LifeMatrix Technologies AG, is a pre-revenue, high-tech startup company spun out of the Institute for Regenerative Medicine at the University of Zurich.
The award winning LifeMatrix technology platform is backed by >20 years of research with >150 peer-reviewed publications and a strong patent portfolio.
Our team combines world leading science in cardiovascular tissue engineering with in-depth entrepreneurial expertise in medical biomimetic device development.
We operate offices based in the Bio-Technopark® Schlieren and collaborate with the Regenerative Medicine Technologies platform of Wyss Zurich.
LifeMatrix received support from Wyss Zurich, a joint accelerator of the University of Zurich and ETH Zurich, as well as Innosuisse, the Swiss Innovation Agency.
Meet the Team
Management Team
Maximilian Emmert, MD, PhD
Co-Founder & Founding CEO
René Stenger
Co-Founder & CTO
Sina Reckel, PhD
Director of Operations
Board of Directors
Maximilian Emmert, MD, PhD
Chairman of the Board
René Stenger
Board Member
Jessica Mann, MD, PhD
Board Member
Urs Christen
Board Member
Clinical and Scientific Advisory Board
Simon P. Hoerstrup, MD, PhD
Co-Founder & Chair Advisory Board
Frank P.T. Baaijens, PhD
Co-Founder & Advisory Board Member
Jessica Mann, MD, PhD
Advisory Board Member
Volkmar Falk, MD
Advisory Board Member
Andre Terzic, MD, PhD
Advisory Board Member
